Jim Cullen
Cullen Value Fund
Cullen Value Fund Portfolio 13F
Jim Cullen Holdings Activity
- Portfolio value:
- $29.98M≈ (-$9M≈)
- Previous value:
- $38.93M≈
- # of changes:
- 40
- New positions:
- 0
- Reported for:
- 31 Dec 2019 (Q4)
- Latest filing date:
- 26 Feb 2020
Cullen Value Fund has disclosed a total of 40 changes to the portfolio in the (2019 Q4) SEC report(s): decreased the number of shares of 36 and completely sold out 4 position(s).
What stocks did Jim Cullen buy in 2019 Q4?
During 2019 Q4 Jim Cullen has not purchased any securities.
In the 2019 Q4 report(s) the following changes have been made to the top investments: (CSCO) Cisco Systems Inc (reduced shares -24.36%), (BMY) Bristol-Myers Squibb Company (reduced shares -25.05%), (JPM) JPMorgan Chase & Co (reduced shares -34.37%), (MRK) Merck & Company Inc (reduced shares -20.92%) and (BAC) Bank of America Corp (reduced shares -27.83%).
40 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
The Boeing Company
|
-8.26%
|
$325.76
|
-26.91%($238.10)
|
3.02%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
Novartis AG ADR
|
-15.31%
|
$94.69
|
+62.15%($153.54)
|
2.57%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
Oracle Corp
|
-16.16%
|
$52.98
|
+179.80%($148.24)
|
2.99%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
ConocoPhillips
|
-17.30%
|
$65.03
|
+81.72%($118.17)
|
2.59%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
Microsoft Corp
|
-17.99%
|
$157.70
|
+214.51%($495.99)
|
2.58%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
Walt Disney Company
|
-18.19%
|
$144.63
|
-31.92%($98.46)
|
2.72%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
The Allstate Corp
|
-19.19%
|
$112.45
|
+132.65%($261.62)
|
2.61%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
Newmont Goldcorp Corp
|
-19.89%
|
$43.45
|
+126.67%($98.49)
|
2.69%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
Medtronic PLC
|
-20.15%
|
$113.45
|
-24.12%($86.08)
|
3.52%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
Merck & Company Inc
|
-20.92%
|
$90.95
|
+41.73%($128.90)
|
3.63%
|
2019 Q3
|
≈ 0.50 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.